PMCB — PHARMACYTE BIOTECH INC
As of Q2 2026, 7 SEC-registered investment managers reported holding PMCB (PHARMACYTE BIOTECH INC) in their latest 13F filings, with a combined reported value of $437.74K across 568.48K shares. That is -30.0% by share count (-243.54K shares) versus the previous quarter, while reported value moved -19.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 added to existing stakes, 5 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
PMCB is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 369.48K | $284.50K | 0.00% | Reduce |
| Geode Capital Management history | 124.25K | $95.68K | 0.00% | Reduce |
| Renaissance Technologies history | 37.99K | $29.25K | 0.00% | Reduce |
| Northern Trust Corp history | 32.62K | $25.12K | 0.00% | Reduce |
| UBS Group AG history | 4.14K | $3.19K | 0.00% | Reduce |
| Morgan Stanley history | 2 | $2 | 0.00% | Add |
| BlackRock Inc history | 1 | $1 | 0.00% | Hold |
Q1 2026 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 519.75K | $345.84K | 0.00% | Add |
| Geode Capital Management history | 195.66K | $130.20K | 0.00% | Add |
| Renaissance Technologies history | 56.50K | $37.59K | 0.00% | Reduce |
| Northern Trust Corp history | 35.60K | $23.69K | 0.00% | Hold |
| UBS Group AG history | 4.52K | $3.00K | 0.00% | Add |
| BlackRock Inc history | 1 | $1 | 0.00% | Hold |
| Morgan Stanley history | 1 | $1 | 0.00% | Reduce |
Q4 2025 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 415.82K | $301.06K | 0.00% | Add |
| Geode Capital Management history | 123.84K | $89.67K | 0.00% | Reduce |
| Renaissance Technologies history | 94.04K | $68.08K | 0.00% | Add |
| Vanguard Group history | 74.92K | $54.24K | 0.00% | Hold |
| Northern Trust Corp history | 35.60K | $25.77K | 0.00% | Add |
| UBS Group AG history | 2.75K | $1.99K | 0.00% | Add |
| Bank of America Corp history | 314 | $227 | 0.00% | Reduce |
| Morgan Stanley history | 2 | $2 | 0.00% | Reduce |
| BlackRock Inc history | 1 | $1 | 0.00% | Hold |
Q3 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 126.60K | $122.77K | 0.00% | Hold |
| Renaissance Technologies history | 80.00K | $77.57K | 0.00% | Add |
| Vanguard Group history | 74.92K | $72.67K | 0.00% | Reduce |
| Citadel Advisors history | 25.13K | $24.37K | 0.00% | New |
| Northern Trust Corp history | 19.21K | $18.62K | 0.00% | Hold |
| UBS Group AG history | 1.32K | $1.28K | 0.00% | Reduce |
| Bank of America Corp history | 538 | $522 | 0.00% | Reduce |
| Morgan Stanley history | 9 | $10 | 0.00% | Add |
| BlackRock Inc history | 1 | $1 | 0.00% | New |
| Citigroup Inc history | 1 | $1 | 0.00% | New |
Q2 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Vanguard Group history | 194.45K | $213.89K | 0.00% | Hold |
| Geode Capital Management history | 126.60K | $139.28K | 0.00% | Reduce |
| Renaissance Technologies history | 49.80K | $54.28K | 0.00% | Add |
| UBS Group AG history | 22.59K | $24.62K | 0.00% | Add |
| Northern Trust Corp history | 19.21K | $20.94K | 0.00% | Hold |
| Bank of America Corp history | 542 | $591 | 0.00% | Add |
| Morgan Stanley history | 1 | $1 | 0.00% | Hold |
Q1 2025 — 11 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Vanguard Group history | 194.52K | $243.15K | 0.00% | Add |
| Geode Capital Management history | 138.94K | $173.69K | 0.00% | Reduce |
| Renaissance Technologies history | 49.50K | $61.88K | 0.00% | Hold |
| Northern Trust Corp history | 19.21K | $24.01K | 0.00% | Hold |
| Citadel Advisors history | 15.80K | $19.75K | 0.00% | Add |
| UBS Group AG history | 11.92K | $14.89K | 0.00% | Add |
| Bank of America Corp history | 73 | $92 | 0.00% | Reduce |
| JPMorgan Chase & Co history | 16 | $20 | 0.00% | Reduce |
| BlackRock Inc history | 14 | $18 | 0.00% | New |
| Fidelity Management & Research (FMR) history | 6 | $8 | 0.00% | New |
| Morgan Stanley history | 1 | $2 | 0.00% | Reduce |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 18 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | 369.48K | 519.75K | 415.82K | 25.13K | — | 15.80K | 13.90K | — | — | 14.36K | 42.42K | 40.38K | 100.41K | 163.41K | 120.00K | 83.50K | 111.10K | 34.50K | 39.30K | 21.30K |
| Geode Capital Management | 124.25K | 195.66K | 123.84K | 126.60K | 126.60K | 138.94K | 164.74K | 168.20K | 176.60K | 200.28K | 215.64K | 219.11K | 219.07K | 175.26K | 175.26K | 175.61K | 175.61K | 171.52K | 83.58K | 46.61K |
| Renaissance Technologies | 37.99K | 56.50K | 94.04K | 80.00K | 49.80K | 49.50K | 49.30K | 49.70K | 48.50K | 43.80K | 38.10K | 32.90K | 25.87K | — | — | — | — | — | — | — |
| Northern Trust Corp | 32.62K | 35.60K | 35.60K | 19.21K | 19.21K | 19.21K | 19.21K | 19.21K | 19.21K | 19.23K | 19.28K | 19.28K | 28.41K | 29.25K | 37.62K | 37.63K | 37.63K | 35.64K | 35.46K | — |
| UBS Group AG | 4.14K | 4.52K | 2.75K | 1.32K | 22.59K | 11.92K | 1.87K | 8.35K | 27.57K | 9 | 13 | 9 | 9 | 1.69K | 9 | 9 | 9 | 5.83K | 3.66K | 3.40K |
| Morgan Stanley | 2 | 1 | 2 | 9 | 1 | 1 | 2 | 2 | 3 | 3 | 4 | 3 | 21 | 31 | 55 | 31 | 2.53K | 61.87K | 68.13K | 1.35K |
| BlackRock Inc | 1 | 1 | 1 | 1 | — | 14 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Bank of America Corp | — | — | 314 | 538 | 542 | 73 | 78 | 117 | 152 | 54 | 62 | 116 | 54 | 54 | 98 | 54 | 1.73K | 58 | 58 | 58 |
| Citigroup Inc | — | — | — | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vanguard Group | — | — | 74.92K | 74.92K | 194.45K | 194.52K | 192.39K | 192.39K | 192.39K | 174.60K | 171.34K | 168.92K | 183.58K | 701.45K | 654.52K | 643.17K | 642.37K | 614.62K | 613.67K | — |
| Fidelity Management & Research (FMR) | — | — | — | — | — | 6 | — | — | — | — | — | — | 1 | — | — | — | — | — | — | 500 |
| JPMorgan Chase & Co | — | — | — | — | — | 16 | 18 | 18 | 19 | 18 | 12 | 17 | — | — | — | — | — | 2.72K | — | — |
| BNY Mellon | — | — | — | — | — | — | — | — | — | — | 16.60K | 16.59K | 16.59K | — | — | — | — | — | — | — |
| Marshall Wace | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 13.52K | — |
| Millennium Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 25.02K | 17.52K | — | — | — |
| Charles Schwab Investment Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 17.22K | — | — | — | — | — |
| T. Rowe Price Associates | — | — | — | — | — | — | — | — | — | — | — | — | — | 25.60K | 36.40K | 47.00K | 62.00K | 78.10K | 78.10K | 133.60K |
| Wells Fargo & Co | — | — | — | — | — | — | — | — | — | 55 | 55 | 53 | 185 | 129 | 141 | 138 | 139 | 128 | 127 | 26 |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details